Shares of Teleflex Inc. TFX slid 2.38% to $135.52 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.49% to 5,599.30 and the ...

NEW YORK, NY / ACCESS Newswire / March 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Teleflex ...

Teleflex's (NYSE: TFX) fourth-quarter 2024 earnings conference call, held on February 27, 2025, revealed significant ...

Teleflex, whose shares sank nearly 20% Thursday, will acquire most of Biotronik’s vascular intervention assets. Teleflex also announced a CFO transition.

Teleflex (NYSE: TFX) announced today that it plans to separate its Urology, Acute Care and OEM businesses into a new publicly traded company.

Teleflex is splitting its business into two independently traded entities, with a completion date set for mid-2026 ...

In conjunction with its Q4 2024 results, MedTech firm Teleflex (NYSE:TFX) announced plans to separate the company’s Urology, ...

Teleflex plans to split into two companies by mid-2026, with RemainCo focusing on high-growth hospital markets and NewCo on urology and OEM. Teleflex will acquire Biotronik's Vascular Intervention ...

Most recently, AcuityMD signed Teleflex Incorporated, a global provider of medical technologies that offers solutions across therapy areas, including interventional urology. Teleflex leverages ...

Investing.com -- Moody’s Ratings has revised the outlook for Teleflex (NYSE:TFX) Incorporated to negative from stable, while affirming the company’s Ba1 Corporate Family Rating (CFR), Ba1-PD ...

Teleflex is separating into two publicly traded companies to optimize growth and shareholder value. The acquisition of Biotronik's Vascular Intervention expands Teleflex's presence in coronary and ...